NeoGenomics, Inc. (NEO)
NASDAQ: NEO · Real-Time Price · USD
14.17
+0.44 (3.20%)
At close: Jun 26, 2026, 4:00 PM EDT
14.06
-0.11 (-0.78%)
After-hours: Jun 26, 2026, 7:55 PM EDT
NeoGenomics Employees
NeoGenomics had 2,500 employees as of December 31, 2025. The number of employees increased by 300 or 13.64% compared to the previous year.
Employees
2,500
Change (1Y)
300
Growth (1Y)
13.64%
Revenue / Employee
$298,388
Profits / Employee
-$39,683
Market Cap
1.85B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| RadNet | 9,276 |
| Sotera Health Company | 3,000 |
| OPKO Health | 2,275 |
| GeneDx Holdings | 1,300 |
| Castle Biosciences | 942 |
| GRAIL | 910 |
| CareDx | 765 |
| Veracyte | 755 |
NEO News
- 3 days ago - NeoGenomics appoints Starrett to its Board of Directors - TheFly
- 3 days ago - NeoGenomics Appoints Carolyn Starrett to its Board of Directors - Business Wire
- 11 days ago - NeoGenomics announces pricing of $275M convertible senior notes offering - TheFly
- 11 days ago - NeoGenomics Announces Pricing of Offering of $275 Million Convertible Senior Notes - Business Wire
- 12 days ago - NeoGenomics files to sell $275M of convertible senior notes due 2032 - TheFly
- 12 days ago - NeoGenomics Announces Proposed Offering of $275 Million Convertible Senior Notes - Business Wire
- 23 days ago - NeoGenomics Transcript: Jefferies Global Healthcare Conference 2026 - Transcripts
- 4 weeks ago - NeoGenomics to Present New Research at ASCO Annual Meeting 2026 - Business Wire